These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17916983)

  • 21. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid Syndrome: It's Far More Than You Think.
    Annem C; Furie RA
    J Clin Rheumatol; 2017 Aug; 23(5):278-284. PubMed ID: 28742725
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome.
    Sciascia S; Radin M; Ramirez C; Seaman A; Bentow C; Casas S; Cecchi I; Rubini E; Foddai SG; Baldovino S; Fenoglio R; Menegatti E; Roccatello D; Mahler M
    Autoimmun Rev; 2020 Oct; 19(10):102641. PubMed ID: 32801044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.
    Abreu MM; Danowski A; Wahl DG; Amigo MC; Tektonidou M; Pacheco MS; Fleming N; Domingues V; Sciascia S; Lyra JO; Petri M; Khamashta M; Levy RA
    Autoimmun Rev; 2015 May; 14(5):401-14. PubMed ID: 25641203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
    Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA
    J Thromb Haemost; 2006 Feb; 4(2):295-306. PubMed ID: 16420554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasculitis in antiphospholipid syndrome.
    Lally L; Sammaritano LR
    Rheum Dis Clin North Am; 2015; 41(1):109-23, ix. PubMed ID: 25399943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid syndrome. Current insights into laboratory diagnosis and pathophysiology.
    van Os GM; Urbanus RT; Agar C; Meijers JC; de Groot PG
    Hamostaseologie; 2010 Aug; 30(3):139-43. PubMed ID: 20680233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome.
    Toubi E; Krause I; Fraser A; Lev S; Stojanovich L; Rovensky J; Blank M; Shoenfeld Y
    Clin Exp Rheumatol; 2005; 23(4):499-504. PubMed ID: 16095119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
    Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D
    Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.
    Comellas-Kirkerup L; Hernández-Molina G; Cabral AR
    Blood; 2010 Oct; 116(16):3058-63. PubMed ID: 20625007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.
    Amengual O; Forastiero R; Sugiura-Ogasawara M; Otomo K; Oku K; Favas C; Delgado Alves J; Žigon P; Ambrožič A; Tomšič M; Ruiz-Arruza I; Ruiz-Irastorza G; Bertolaccini ML; Norman GL; Shums Z; Arai J; Murashima A; Tebo AE; Gerosa M; Meroni PL; Rodriguez-Pintó I; Cervera R; Swadzba J; Musial J; Atsumi T
    Lupus; 2017 Mar; 26(3):266-276. PubMed ID: 27510605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome.
    Chaudhary H; Jindal P; Pandiarajan V; Kumar J; Sudhakar M; Ezhumalai G; Nada R; Gupta K
    Lupus; 2021 Jan; 30(1):141-148. PubMed ID: 33086918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?
    Noureldine MHA; Haydar AA; Berjawi A; Elnawar R; Sweid A; Khamashta MA; Hughes GRV; Uthman I
    Immunol Res; 2017 Feb; 65(1):230-241. PubMed ID: 27423434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.